@article{6d682ef033594592a4eb09957770ad58,
title = "Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma",
keywords = "advanced renal cell carcinoma, KDR, polymorphism, sunitinib, vascular endothelial growth factor receptor 2, SINGLE-NUCLEOTIDE POLYMORPHISMS, 1ST-LINE SUNITINIB, INDUCED TOXICITY, MARKERS, THERAPY, VEGFR2, IDENTIFICATION, HYPERTENSION, ASSOCIATION, PAZOPANIB",
author = "Maria Apellaniz-Ruiz and Diekstra, {Meta H.} and Roldan, {Juan M.} and Epie Boven and Daniel Castellano and Hans Gelderblom and Mathijssen, {Ron H. J.} and Swen, {Jesse J.} and Stefan Bohringer and Jesus Garcia-Donas and Rini, {Brian I.} and Henk-Jan Guchelaar and Cristina Rodriguez-Antona",
year = "2017",
month = jun,
doi = "10.1097/FPC.0000000000000280",
language = "English",
volume = "27",
pages = "227--231",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "6",
}